Article Details
Retrieved on: 2021-02-22 13:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Pat McIver told BioProcess Insider it is investing £350 million ($490 million) to build a new site which will produce monoclonal antibodies (mAbs).
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here